tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Income Statement

Compare
0 Followers

SynAct Pharma AB Income Statement

Last quarter (Q4 2024), SynAct Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, SynAct Pharma AB's net income was kr-18.38M. See SynAct Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -778.00Kkr -1.06Mkr -88.00Kkr 0.00kr -338.51K
Operating Expenses
kr 224.50Mkr 105.71Mkr 76.70Mkr 31.29Mkr 24.80M
Depreciation and Amortization
kr 778.00Kkr 1.06Mkr 88.00Kkr 381.06Kkr 338.51K
EBITDA
kr -222.70Mkr -105.71Mkr -76.62Mkr -30.90Mkr -25.01M
Operating Income
kr -224.50Mkr -105.70Mkr -76.70Mkr -31.29Mkr -24.80M
Other Income/Expenses
kr 220.00Kkr -1.36Mkr -110.00Kkr -19.00Kkr -2.30M
Pretax Income
kr -224.28Mkr -107.06Mkr -76.81Mkr -31.30Mkr -27.10M
Net Income
kr -215.81Mkr -99.20Mkr -69.30Mkr -26.55Mkr -23.96M
Per Share Metrics
Basic EPS
kr -6.64kr -3.60kr -2.67kr -1.23kr -1.62
Diluted EPS
kr -6.64kr -3.60kr -2.67kr -1.23kr -1.62
Weighted Average Shares Outstanding
32.52M 27.59M 25.97M 21.65M 14.82M
Weighted Average Shares Outstanding (Diluted)
32.52M 27.59M 25.97M 21.65M 14.82M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis